Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
No trend data available for this metric.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $736.5M 100.0% | $792.1M 100.0% | $1.25B 100.0% | $1.58B 100.0% | $1.19B 100.0% | $695.0M 100.0% | $384.9M 100.0% |
| Cost of Revenue | $662.8M 90.0% | $733.1M 92.5% | $1.23B 98.3% | $1.54B 97.5% | $1.12B 93.6% | $634.8M 91.3% | $340.7M 88.5% |
| Research & Development | $38.8M 5.3% | $40.7M 5.1% | $61.9M 4.9% | $57.2M 3.6% | $33.6M 2.8% | $21.0M 3.0% | $14.0M 3.6% |
| Selling, General & Admin | $145.3M 19.7% | $137.6M 17.4% | $145.9M 11.6% | $183.5M 11.6% | $113.3M 9.5% | $64.9M 9.3% | $28.4M 7.4% |
| Total Operating Expenses | $939.9M 127.6% | $1.05B 132.7% | $1.70B 135.4% | $2.14B 135.4% | $1.40B 117.0% | $757.9M 109.1% | $463.0M 120.3% |
| Operating Income | -$203.4M -27.6% | -$258.8M -32.7% | -$443.6M -35.4% | -$560.0M -35.4% | -$203.3M -17.0% | -$63.0M -9.1% | -$78.1M -20.3% |
| Interest Expense | $90.5M 12.3% | $65.4M 8.3% | $41.3M 3.3% | $7.5M 0.5% | $9.5M 0.8% | $23.0M 3.3% | $29.4M 7.6% |
| Other Income (Expense), net | -$87.3M -11.9% | -$79.6M -10.1% | -$42.4M -3.4% | $4.6M 0.3% | $6.1M 0.5% | -$22.4M -3.2% | -$28.7M -7.5% |
| Pretax Income | -$290.7M -39.5% | -$338.4M -42.7% | -$486.0M -38.8% | -$555.4M -35.2% | -$197.2M -16.5% | -$85.4M -12.3% | -$106.9M -27.8% |
| Income Tax Expense | $3.5M 0.5% | $1.2M 0.2% | $1.4M 0.1% | $170K 0.0% | $58K 0.0% | $0 0.0% | $0 0.0% |
| Net Income | -$294.2M -39.9% | -$339.6M -42.9% | -$487.4M -38.9% | -$555.2M -35.1% | -$190.0M -15.9% | -$78.6M -11.3% | -$96.3M -25.0% |
| Per Share | |||||||
| EPS (Basic) | $-0.42 | $-0.49 | $-3.69 | $-22.60 | $-9.28 | $-0.48 | $-0.93 |
| EPS (Diluted) | $-0.42 | $-0.49 | $-3.69 | $-22.60 | $-9.28 | $-0.48 | $-0.93 |
| Weighted Avg Shares (Basic) | 706.0M | 697.7M | 132.2M | 24.6M | 20.5M | 162.5M | 103.8M |
| Weighted Avg Shares (Diluted) | 706.0M | 697.7M | 132.2M | 24.6M | 20.5M | 162.5M | 103.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $2M buybacks = $2M returned on -$260M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 7 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 388%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 7 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $134M covers the $27M due within a year 5.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2022-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~28.6% on $316M of debt.
Cash of $134M fully covers short-term debt of $19M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-08-05
Where each multiple sits in its own 6-yr range · 0th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 6-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 3.0× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cost of Revenue | 88.5 | 91.3 | 93.6 | 97.5 | 98.3 | 92.5 | 90.0 |
| R&D | 3.6 | 3.0 | 2.8 | 3.6 | 4.9 | 5.1 | 5.3 |
| SG&A | 7.4 | 9.3 | 9.5 | 11.6 | 11.6 | 17.4 | 19.7 |
| Operating Income | -20.3 | -9.1 | -17.0 | -35.4 | -35.4 | -32.7 | -27.6 |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.5 |
| Net Income | -25.0 | -11.3 | -15.9 | -35.1 | -38.9 | -42.9 | -39.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on UP: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.